Byrne Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$105K Sell
1,819
-64
-3% -$3.67K 0.06% 240
2026
Q1
$114K Sell
1,883
-396
-17% -$23.1K 0.07% 208
2025
Q4
$123K Buy
2,279
+481
+27% +$23.1K 0.07% 194
2025
Q3
$81.1K Sell
1,798
-350
-16% -$16.3K 0.05% 178
2025
Q2
$99.4K Buy
2,148
+899
+72% +$44.1K 0.07% 156
2025
Q1
$76.2K Hold
1,249
0.06% 169
2024
Q4
$70.6K Buy
1,249
+75
+6% +$4.19K 0.05% 174
2024
Q3
$60.7K Sell
1,174
-320
-21% -$15K 0.04% 186
2024
Q2
$62K Sell
1,494
-234
-14% -$10.5K 0.04% 185
2024
Q1
$93.7K Sell
1,728
-415
-19% -$21.1K 0.06% 160
2023
Q4
$110K Sell
2,143
-937
-30% -$49.2K 0.08% 141
2023
Q3
$179K Sell
3,080
-30
-1% -$1.84K 0.15% 110
2023
Q2
$199K Sell
3,110
-85
-3% -$5.7K 0.13% 144
2023
Q1
$221K Sell
3,195
-1,000
-24% -$70.5K 0.16% 126
2022
Q4
$302K Sell
4,195
-1,144
-21% -$86.3K 0.22% 108
2022
Q3
$380K Sell
5,339
-210
-4% -$15.2K 0.29% 94
2022
Q2
$427K Buy
5,549
+4,198
+311% +$320K 0.32% 76
2022
Q1
$99K Sell
1,351
-73
-5% -$4.9K 0.06% 164
2021
Q4
$89K Buy
+1,424
New +$83.5K 0.06% 178

Other funds holding BMY

Byrne Asset Management's BMY Position: Q2 2026 in Review

Byrne Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 3.4% in Q2 2026, selling an estimated $3.67K and leaving 1,819 shares worth $105K. The position accounts for 0.06% of the portfolio, ranked #240.

Byrne Asset Management first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $427K in Q2 2022. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Byrne Asset Management held 1,819 shares of Bristol-Myers Squibb worth $105K as of Q2 2026.
  • Byrne Asset Management sold 64 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.67K.
  • Bristol-Myers Squibb made up 0.06% of Byrne Asset Management's portfolio in Q2 2026, its #240 holding.
  • Byrne Asset Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
  • Byrne Asset Management's Bristol-Myers Squibb position peaked at $427K in Q2 2022.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.